The p53 Saga: Early Steps in the Development of Tumor Immunotherapy-Reference-Cited by-同舟云学术

The p53 Saga: Early Steps in the Development of Tumor Immunotherapy

Published:2020-04-20 Issue:9 Volume:204 Page:2321-2328
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

DeLeo Albert B.,Appella Ettore

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference54 articles.

1. Unique and common tumor-specific transplantation antigens of chemically induced mouse sarcomas.;Hellström;Int. J. Cancer,1978

2. ANTIGENIC PROPERTIES OF CHEMICALLY INDUCED TUMORS*

3. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.;Bloom;J. Natl. Cancer Inst.,1970

4. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.

5. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p53 mutation and deletion contribute to tumor immune evasion;Frontiers in Genetics;2023-02-20

2. Multi-Omic Analysis of Two Common P53 Mutations: Proteins Regulated by Mutated P53 as Potential Targets for Immunotherapy;Cancers;2022-08-17

3. Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer;Biomolecules;2022-04-06

4. Impact of the tumor immune microenvironment on the outcome of pancreatic cancer: a retrospective study based on clinical pathological analysis;Gland Surgery;2022-02

5. Clinical and Immunological Effects of p53-Targeting Vaccines;Frontiers in Cell and Developmental Biology;2021-11-03